CRBN and leukemia: We expressed all combinations of Crbn S105F, E152D, V380E, and I391V in the mouse leukemia cell line Ba/F3 and assessed the impact on protein degradation and cell viability following exposure to CC-885 (Figure 4, A–C, and Supplemental Figure 4, B–D).